Concepedia

Christopher MacLauchlin

CM

Statistics

Publications

4

Citations

200

H-Index

4

Active since

2011

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

Christopher MacLauchlin is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, pharmacokinetics, and drug metabolism.

Publications per year

2011–2021

4

Publications

4

Human Metabolism of Lapatinib, a Dual Kinase Inhibitor: Implications for Hepatotoxicity

Stephen Castellino, Michael O'Mara, Kevin M. Koch et al. · Drug Metabolism and Disposition · 2011 · 103 citations

, , +17

Contribution of Metabolites to P450 Inhibition–Based Drug–Drug Interactions: Scholarship from the Drug Metabolism Leadership Group of the Innovation and Quality Consortium Metabolite Group

Hongbin Yu, Suresh K. Balani, Wei‐Chao Chen et al. · Drug Metabolism and Disposition · 2015 · 36 citations

, , +17

Utilizing Drug-Drug Interaction Prediction Tools during Drug Development: Enhanced Decision Making Based on Clinical Risk

Carole Shardlow, Grant T. Generaux, Christopher MacLauchlin et al. · Drug Metabolism and Disposition · 2011 · 33 citations

, , +17

Clinical and Preclinical Single-Dose Pharmacokinetics of VIR-2218, an RNAi Therapeutic Targeting HBV Infection

Sneha Gupta, Marie C. Fanget, Christopher MacLauchlin et al. · Drugs in R&D · 2021 · 28 citations · Full text

, , +17

1–4 of 4